canakinumab in the treatment of active hyperimmunoglobulinaemia d with periodic fever syndrome
Published 8 years ago • 1.4K plays • Length 6:01Download video MP4
Download video MP3
Similar videos
-
5:09
pathophysiology and treatment of hyperimmunoglobulinaemia d with periodic fever syndrome (hids)
-
2:58
patients with caps still improving on long-term canakinumab
-
1:26:21
tnf receptor associated periodic syndrome & hyper igd syndrome - dr helen j lachmann
-
0:31
get rid of allergic rhinitis forever! #shorts
-
1:20
asthma and the difference between hvni and hfnc
-
2:21
antiinflammatory therapy and cardiovascular events
-
2:04
rna sequencing of single allergen-specific memory b cells after grass pollen immunotherapy
-
50:07
xanthines, pde inhibitors and chromones (stout)
-
0:16
tips to manage hay fever #shorts
-
4:28
reduced-intensity induction dasatinib vs hypercvad tkis in ph all
-
2:37
the addition of inotuzumab ozogamicin to hyper-cvad blinatumomab in patients with b-all
-
1:05
hay fever and seasonal allergies
-
4:06
doctor explains hay fever symptoms and treatment (allergic rhinitis)
-
0:50
how antibiotic overuse could lead to hay fever
-
34:13
[david hildeman] il-10producing tfh cells accumulate with age and link inflammation with age-related
-
2:09
common issues among asthma, epilepsy, and schizophrenia: from inflammation to ca2 /camp signalling
-
15:00
john affeldt, md, mph - recombinant human ngf for treatment of neurotrophic keratitis
-
1:51
peripheral markers of allergen‐specific immune activation predict clinical allergy in eoe
-
2:22
hovakim grabski - breaking the wall of antibiotic resistant pseudomonas aeruginosa